Man with head on pregnant woman's stomach on a couch

Your partner for preconception, pregnancy and pediatric care worldwide

Labcorp Women’s Health & Genetics – International

Explore Labcorp's cutting-edge noninvasive prenatal genetic screening options, including MaterniT® for cell-free DNA screening, Inheritest® for comprehensive carrier screening, and donor infectious disease testing. Benefit from our extensive clinical expertise and services designed to enhance patient experiences at every stage of life.

Prenatal cfDNA screening (NIPT)

Since the acquisition of Sequenom in 2016, Labcorp offers the first globally commercialized prenatal cfDNA screening test, MaterniT 21 PLUS, and the first genome-wide prenatal cfDNA screening test, MaterniT GENOME. We also offer GENOME-Flex, which provides an alternative pathway when late-stage anomalies are suspected. GENOME-Flex allows us to rapidly re-sequence previously run MaterniT 21 PLUS samples using the deeper sequencing power of MaterniT GENOME, giving you options if a second prenatal cfDNA screen is required.

Labcorp offers

  • More prenatal cfDNA screening options
    • Sex chromosomes 
    • Microdeletions 
    • Reflex option
    • Mosaicism Ratio reporting
    • Fetal sex for twin gestations
  • Fewer redraws requested: overall NRR = 0.9%
  • GENOME-Flex results available in approximately 72 hours
Provider talking to a young woman at an appointment. The provider is showing the woman a clipboard

Every pregnancy is unique. MaterniT delivers results whether you are managing routine or high-risk pregnancies which may include:

  • Higher maternal weight
  • Twins and multiple gestations
  • Egg donor/IVF
  • Complex family history
  • Mosaicism

After performing more than 3 million prenatal cfDNA screening tests, we know that not all positive results are created equal. The Mosaicism Ratio result, only available with MaterniT 21 PLUS (at no extra cost), can refine your patient's risk for aneuploidy by helping to differentiate between a positive result that is more likely to be a true positive, and one with an increased chance to be a false positive.1

 

Learn more about our Prenatal cfDNA Screening profile

Learn more about Mosaicism Ratio result

Mosaicism Ratio in Multifetal Gestations Brochure

International Presence

We support our global partners and patients in over 50+ countries worldwide and aim to be your dedicated partner 
for leading-edge medical laboratory tests and services.

International Distributors Womens Health

Have a question? Let us assist you.

Additional resources

video clapper icon

Watch

Mosaicism ratio clinical presentation

 

video clapper icon

Watch

Patient education videos (English)

 

video clapper icon

Mirar

Vídeos educativos para pacientes (Español)

 

References

  1. Rafalko J. et al. NIPT Mosaicism Ratio; increasing confidence in NIPT results. Pren. Diag. 2020